Last reviewed · How we verify
NCT05006131: PancreasScan
Pancreatic Cancer Screening for At-risk Individuals
trial testing Screening for pancreatic cancer in Pancreatic Cancer, Adult in 1,395 participants. Currently enrolling.
31 December 2032
Quick facts
| Lead sponsor | Beth Israel Deaconess Medical Center |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 1,395 |
| Start date | 10 July 2020 |
| Primary completion | 31 December 2032 |
| Estimated completion | 31 December 2032 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Screening for pancreatic cancer
Conditions studied
- Pancreatic Cancer, Adult — all drugs for Pancreatic Cancer, Adult →
Sponsor
Beth Israel Deaconess Medical Center
Who can join
Adults 18 to 90, any sex, with Pancreatic Cancer, Adult. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators' goal is to conduct a prospective multicenter study to evaluate the yield and outcomes of screening of pancreas cancer in individuals who are at-risk for pancreatic cancer. We plan to use International Cancer of the Pancreas Screening (CAPS3) Consortium recommendations to standardize study population, screening methodology, and study outcomes.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
BRCA1, BRCA2, and Associated Cancer Risks and Management for Male Patients: A Review.
Cheng HH, Shevach JW, Castro E, Couch FJ, et al · · 2024 · cited 30× · PMID 39052257 · DOI 10.1001/jamaoncol.2024.2185 -
Pancreatic Cancer Screening for At-Risk Individuals (Pancreas Scan Study): Yield, Harms, and Outcomes From a Prospective Multicenter Study.
Shah I, Silva-Santisteban A, Germansky KA, Trindade A, et al · · 2023 · cited 13× · PMID 37141538 · DOI 10.14309/ajg.0000000000002314 -
Current Approaches of Pancreatic Cancer Surveillance in High-Risk Individuals.
Heller M, Mann DA, Katona BW. · · 2025 · cited 3× · PMID 39932614 · DOI 10.1007/s12029-025-01184-1
Verify or expand the search:
- PubMed search for NCT05006131
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pancreatic Cancer, Adult
Currently open trials in the same condition.
- NCT06717295 — The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cel · recruiting
- NCT06852014 — Effects of Peptamen 1.6 in Malnourished Patients (or at Risk) With Pancreatic Neoplasia Undergoing Cephalic Pancreaticod · NA · recruiting
- NCT06584227 — Adebrelimab and Chidamide for Pancreatic Cancer · Phase 2 · recruiting
- NCT06388967 — Pancreatic Cancer Detection Consortium · recruiting
- NCT06822413 — Raman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early Diagnosis · recruiting
Other Beth Israel Deaconess Medical Center trials
Trials by the same sponsor.
- NCT07352657 — Remote Alert Pathway To Optimize CaRe of Cardiac Implantable Electrical Devices: The RAPTOR-CIED Study (Main Phase) · NA · not yet recruiting
- NCT07531602 — Effect of PEEP on Cardiac Function · NA · not yet recruiting
- NCT07534683 — Primed to Thrive: Investigating the Combined Impact of Mindfulness Education and Meditation Practice on Psychological an · NA · not yet recruiting
- NCT07277244 — Low-Intensity Mechanical Ventilation in the Operating Room: a Pilot Study · NA · enrolling by invitation
- NCT06896474 — SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05006131 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Beth Israel Deaconess Medical Center
- Last refreshed: 7 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05006131.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing